Biophytis Announces the Design of its Phase 2 OBA Clinical Study in pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Biophytis / Key word(s): MiscellaneousBiophytis is deploying its partnership strategy in obesity 29-Apr-2024 / 14:39 CET/CESTBiophytis is deploying its partnership strategy in obesity Paris (France) and Cambridge (Massachusetts, USA), April 29, 2024 – 07:00 am CET – Biophytis SA (Euronext Growth Paris : ALBPS),.
Biophytis / Key word(s): MiscellaneousBiophytis Announces Transfer of ADSs to OTC Market 24-Apr-2024 / 23:00 CET/CESTBiophytis Announces Transfer of ADSs to OTC Market ADSs delisted from Nasdaq, which will result in meaningful savings ADSs transferred to OTC Pink market; Company will apply to trade on OTCQB ma.
Biophytis Announces Transfer of ADSs to OTC Market saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.